In the context of Klotho, there is also evidence that the blood pressure independent effects of RAS inhibition on cardio‐renal protection in people with diabetes and CKD may be in part be driven by changes in arterial ageing as assessed by Ao‐PWV and increase in levels of Klotho.101, 102. Here, KL is linked to diabetes mellitus.